Future Oncology

Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis

Future Oncology, Ahead of Print.

Future Oncology

23m

Excess of second tumors in denosumab-treated patients: a metabolic hypothesis

Future Oncology, Ahead of Print.

Future Oncology

23m

Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis

Future Oncology, Ahead of Print.

Future Oncology

23m

Preoperative high c-reactive protein/albumin ratio is a poor prognostic factor of oral squamous cell carcinoma

Future Oncology, Ahead of Print.

Future Oncology

23m

Clinical implications of mismatch repair deficiency in prostate cancer

Future Oncology, Ahead of Print.

Future Oncology

23m

Management of distal ureter and bladder cuff at the time of nephroureterectomy: surgical techniques and predictors of outcome

Future Oncology, Ahead of Print.

Future Oncology

23m

Predictive value of PD-L1 and other clinical factors for chemoimmunotherapy in advanced non-small-cell lung cancer

Future Oncology, Ahead of Print.

Future Oncology

23m

Bladder cancer mortality after a diagnosis of nonmuscle-invasive bladder carcinoma

Future Oncology, Ahead of Print.

Future Oncology

23m